The Medicines Co. (MDCO)

52.85
0.84 1.60
NASDAQ : Health Technology
Prev Close 52.01
Open 52.03
Day Low/High 51.48 / 52.94
52 Wk Low/High 16.69 / 53.19
Volume 247.18K
Avg Volume 2.08M
Exchange NASDAQ
Shares Outstanding 79.35M
Market Cap 4.15B
EPS -4.00
P/E Ratio N/A
Div & Yield N.A. (N.A)
The Medicines Company Announces Participation At IDWeek 2015 Meeting

The Medicines Company Announces Participation At IDWeek 2015 Meeting

The Medicines Company today announced that it will make four presentations on its infectious disease programs at IDWeek between October 7 - 11 in San Diego, CA.

The Medicines Company Announces BARDA Exercises Next Option On Contract For Support Of The Development Of CARBAVANCE® (meropenem/RPX7009) For Drug-Resistant Gram-Negative Pathogens

The Medicines Company Announces BARDA Exercises Next Option On Contract For Support Of The Development Of CARBAVANCE® (meropenem/RPX7009) For Drug-Resistant Gram-Negative Pathogens

The Medicines Company (NASDAQ:MDCO) today announced that Rempex Pharmaceuticals, a wholly owned subsidiary, has been awarded the next option on a contract by the Biomedical Advanced Research and Development Authority...

10 Best Nasdaq Biotech Stocks in the Third Quarter

10 Best Nasdaq Biotech Stocks in the Third Quarter

Here are the 10 stocks in the biotech sector which had the best third-quarter.

Short Interest Makes 17.2% Move For MDCO

Short Interest Makes 17.2% Move For MDCO

The most recent short interest data has been released by the NASDAQ for the 09/15/2015 settlement date, which shows a 2,185,141 share increase in total short interest for Medicines Co , to 14,884,599, an increase of 17.21% since 08/31/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

First Week Of November 20th Options Trading For Medicines

First Week Of November 20th Options Trading For Medicines

Investors in Medicines Co saw new options begin trading this week, for the November 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MDCO options chain for the new November 20th contracts and identified one put and one call contract of particular interest.

The Medicines Company Receives CHMP Positive Opinion For IONSYS® To Treat Post-operative Pain In Adult Patients

The Medicines Company Receives CHMP Positive Opinion For IONSYS® To Treat Post-operative Pain In Adult Patients

The Medicines Company today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending marketing authorization for IONSYS® (40...

Trade-Ideas: Medicines Company (MDCO) Is Today's Post-Market Leader Stock

Trade-Ideas: Medicines Company (MDCO) Is Today's Post-Market Leader Stock

Trade-Ideas LLC identified Medicines Company (MDCO) as a post-market leader candidate

The Medicines Company Reports Discovery Of New Series Of Beta-Lactamase Inhibitors At ICAAC/ICC 2015

The Medicines Company Reports Discovery Of New Series Of Beta-Lactamase Inhibitors At ICAAC/ICC 2015

Researchers at The Medicines Company presented data today on a new series of Beta-Lactamase Inhibitors (BLIs) at the Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and the International Congress of...

New Treatment Options For Carbapenem-Resistant Enterobacteriaceae (CRE) Infection Needed, According To Study By The Medicines Company

New Treatment Options For Carbapenem-Resistant Enterobacteriaceae (CRE) Infection Needed, According To Study By The Medicines Company

Researchers at The Medicines Company presented data from a multi-national cohort that demonstrates the mortality and morbidity, and poor outcomes, associated with current therapies in patients with infections due to...

The Medicines Company Announces Participation At ICAAC/ICC 2015 Meeting

The Medicines Company Announces Participation At ICAAC/ICC 2015 Meeting

The Medicines Company (NASDAQ:MDCO) today announced that 18 presentations on its infectious disease programs will be presented at the Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and the...

Medicines Company (MDCO) Hits New Lifetime High Today

Medicines Company (MDCO) Hits New Lifetime High Today

Trade-Ideas LLC identified Medicines Company (MDCO) as a new lifetime high candidate

MATRIX Trial Results Presented At Hot Line Session Of ESC Congress 2015 And Simultaneously Published In The New England Journal Of Medicine

MATRIX Trial Results Presented At Hot Line Session Of ESC Congress 2015 And Simultaneously Published In The New England Journal Of Medicine

The Medicines Company (NASDAQ:MDCO) today announced that The New England Journal of Medicine (NEJM) has published results from the antithrombin program of the MATRIX trial, a large international, open label, multicenter...

Medicines Company (MDCO) Reaches New Lifetime High Today

Medicines Company (MDCO) Reaches New Lifetime High Today

Trade-Ideas LLC identified Medicines Company (MDCO) as a new lifetime high candidate

Analysis From CHAMPION PHOENIX Trial Highlight The Efficacy Of Cangrelor Among Patients Undergoing PCI Via The Radial Approach

Analysis From CHAMPION PHOENIX Trial Highlight The Efficacy Of Cangrelor Among Patients Undergoing PCI Via The Radial Approach

Researchers at ESC Congress 2015 presented data from secondary analyses of the CHAMPION PHOENIX trial comparing cangrelor, The Medicines Company's fast-acting, rapid offset, intravenous antiplatelet agent, to oral...

Market News: The Medicine Company, Netflix, Twitter

Market News: The Medicine Company, Netflix, Twitter

The stock markets in the United States declined today with the S&P 500 heading towards its worst month in more than three years. The index dropped 0.84% to 1,972.07 points today. The S&P 500 d...

Market Wrap: Manic Month Ends With a Loss

Energy stocks rally as price of oil climbs.

3 High-Volume Stocks to Trade Now (or Not)

3 High-Volume Stocks to Trade Now (or Not)

Here's a technical look at some of the most active stocks on the market today.

3 Health Care Stocks Nudging The Sector Higher

3 Health Care Stocks Nudging The Sector Higher

TheStreet highlights 3 stocks pushing the health care sector higher today.

Medicines (MDCO) Stock Skyrockets Following Promising Cholesterol Drug Results

Medicines (MDCO) Stock Skyrockets Following Promising Cholesterol Drug Results

Medicines (MDCO) stock is soaring on Monday after the drug maker along with Alnylam Pharmaceuticals (ALNY) announced positive results of a new cholesterol drug.

Medicines Company (MDCO) Moving On Heavy Volume In The Pre-Market Hours

Medicines Company (MDCO) Moving On Heavy Volume In The Pre-Market Hours

Trade-Ideas LLC identified Medicines Company (MDCO) as a pre-market mover with heavy volume candidate

The Medicines Company Appoints Dr. Fred Eshelman As Non-Executive Chairman Of The Board

The Medicines Company Appoints Dr. Fred Eshelman As Non-Executive Chairman Of The Board

The Medicines Company (NASDAQ:MDCO) today announced that its Board of Directors has named Dr.

(Graphic: Business Wire)

(Graphic: Business Wire)

Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), a leading RNAi therapeutics company, and The Medicines Company (Nasdaq:MDCO), a global biopharmaceutical company focusing on saving lives, alleviating suffering and...

Analysts' Actions -- Akamai, Borg Warner, Urban Outfitters, United States Steel and More

Analysts' Actions -- Akamai, Borg Warner, Urban Outfitters, United States Steel and More

Here are Friday's top research calls, including downgrades for Borg Warner and United States Steel and an upgrade for Akamai Technologies.

The Medicines Company Announces Participation At 2015 European Society Of Cardiology (ESC) Congress In London

The Medicines Company Announces Participation At 2015 European Society Of Cardiology (ESC) Congress In London

The Medicines Company today announced it will present results of recent clinical studies from its cardiovascular product portfolio at the 2015 European Society of Cardiology (ESC) Congress in London, August 29 to September...

The Medicines Co. (MDCO) Stock Price Target Raised at Leerink

The Medicines Co. (MDCO) Stock Price Target Raised at Leerink

The Medicines Co. (MDCO) price target was increased to $40 from $35 at Leerink, which reiterated its 'outperform' rating.

Today's Weak On High Volume Stock: Medicines Company (MDCO)

Today's Weak On High Volume Stock: Medicines Company (MDCO)

Trade-Ideas LLC identified Medicines Company (MDCO) as a weak on high relative volume candidate

The Medicines Company Reports Second-Quarter And First-Half 2015 Financial Results

The Medicines Company Reports Second-Quarter And First-Half 2015 Financial Results

The Medicines Company (NASDAQ:MDCO) today announced its financial results for the second quarter and first half of 2015.

The Medicines Company To Announce Second Quarter Financial Results On Wednesday July 29, 2015

The Medicines Company To Announce Second Quarter Financial Results On Wednesday July 29, 2015

The Medicines Company (NASDAQ:MDCO) has scheduled its quarterly conference call for Wednesday, July 29 th at 8:30 a.

The Medicines Company Authorizes Generic Launch Of ANGIOMAX® (bivalirudin)

The Medicines Company Authorizes Generic Launch Of ANGIOMAX® (bivalirudin)

The Medicines Company (NASDAQ:MDCO) today announced an agreement with Sandoz Inc.

4 Stocks Rising on Unusual Volume

4 Stocks Rising on Unusual Volume

Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.